Abstract
The cases presented in this chapter demonstrate the amazing improvement in wound-healing trajectory that is best explained by the suppression of biofilms. The individual patient with a chronic wound is not much better served today than a decade ago despite all of the advances achieved. The rate of major limb amputation and mortality is not decreasing, and the quality of life of these patients is not improving. Chronic wounds have a much higher prevalence rate of biofilms than acute ones, suggesting that presence of a biofilm is an important factor in the lack of healing of chronic wounds. As shown in this chapter, the implementation of the quorum-sensing inhibitor RNAIII-inhibiting peptide in managing complex wounds, along with other anti-biofilm strategies like lactoferrin, has dramatically changed the positive outcomes for many of the most desperate wounds.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, MacLaren DM, de Graaff J, Nuijens JH (1994) Lactoferrin is a lipid A-binding protein. Infect Immun 62:2628–2632
Arnold RR, Cole MF, McGhee JR (1977) A bactericidal effect for human lactoferrin. Science 197:263–265
Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G (2005) Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop Relat Res 437:48–54
Brandenburg K, Jurgens G, Muller M, Fukuoka S, Koch MH (2001) Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol Chem 382:1215–1225
Bullen JJ (1975) Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Postgrad Med J 51(suppl 3):67–70
Buzato MA, Tribulatto EC, Costa SM, Zorn WG, van Bellen B (2002) Major amputations of the lower leg. The patients two years later. Acta Chir Belg 102:248–252
Costerton JW (2005) Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 437:7–11
Costerton JW, Stewart PS (2001) Battling biofilms. Sci Am 285:74–81
Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322
Diegelmann RF (2003) Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen 11:490–495
Domenico P, Gurzenda E, Giacometti A, Cirioni O, Ghiselli R, Orlando F, Korem M, Saba V, Scalise G, Balaban N (2004) BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. Peptides 25:2047–2053
Ellison RT III, Giehl TJ, LaForce FM (1988) Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 56:2774–2781
Falanga V (2001) Introduction, overview. In: Falanga V (ed) Cutaneous wound healing. Martin Dunitz, London, p 2
Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol 13:34–40
Katsuyama M, Kobayashi Y, Ichikawa H, Mizuno A, Miyachi Y, Matsunaga K, Kawashima M (2005) A novel method to control the balance of skin microflora. Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin. J Dermatol Sci 38:207–213
Ochoa TJ, Noguera-Obenza M, Ebel F, Guzman CA, Gomez HF, Cleary TG (2003) Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect Immun 71:5149–5155
Peters EJ, Childs MR, Wunderlich RP, Harkless LB, Armstrong DG, Lavery LA (2001) Functional status of persons with diabetes-related lower-extremity amputations. Diabetes Care 24:1799–1804
Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 184:1140–1154
Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417:552–555
Smith A (2004) Etiology of the problem wound. In: Sheffield PJ, Fife CE, Smith A (eds) Wound care practice. Best, Flagstaff, pp 3–48
Stoodley P, Sauer K, Davies DG, Costerton JW (2002) Biofilms as complex differentiated communities. Annu Rev Microbiol 56:187–209
Tapiainen T, Sormunen R, Kaijalainen T, Kontiokari T, Ikaheimo I, Uhari M (2004) Ultrastructure of Streptococcus pneumoniae after exposure to xylitol. J Antimicrob Chemother 54:225–228
Veloira WG, Domenico P, LiPuma JJ, Davis JM, Gurzenda E, Kazzaz JA (2003) In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia cepacia complex. J Antimicrob Chemother 52:915–919
Ward PP, Uribe-Luna S, Conneely OM (2002) Lactoferrin and host defense. Biochem Cell Biol 80:95–102
Weinberg ED (1993) The development of awareness of iron-withholding defense. Perspect Biol Med 36:215–221
Weinberg ED (2004) Suppression of bacterial biofilm formation by iron limitation. Med Hypotheses 63:863–865
Yager DR, Nwomeh BC (1999) The proteolytic environment of chronic wounds. Wound Repair Regen 7:433–441
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wolcott, R.D. (2007). Clinical Wound Healing Using Signal Inhibitors. In: Balaban, N. (eds) Control of Biofilm Infections by Signal Manipulation. Springer Series on Biofilms, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7142_2007_015
Download citation
DOI: https://doi.org/10.1007/7142_2007_015
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-73852-7
Online ISBN: 978-3-540-73853-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)